Detalhe da pesquisa
1.
Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial.
Lancet
; 400(10358): 1103-1116, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36099926
2.
Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.
Lancet Oncol
; 15(9): 1007-18, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24965569
3.
Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma.
JAMA Oncol
; 8(2): 275-280, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34940781
4.
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study.
J Clin Oncol
; 39(33): 3725-3736, 2021 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34491815
5.
Smoking cessation: an integral part of lung cancer treatment.
Oncology
; 78(5-6): 289-301, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20699622
6.
Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.
Lung Cancer
; 64(1): 51-9, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18701186
7.
A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer.
Clin Lung Cancer
; 18(6): 615-625.e8, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28601388
8.
Patient preferences in choosing chemotherapy regimens for advanced non-small cell lung cancer.
J Support Oncol
; 3(2): 149-54, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15796447
9.
Update in lung cancer 2008.
Am J Respir Crit Care Med
; 179(10): 860-8, 2009 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19423719
10.
Phase I trial of perillyl alcohol administered four times daily continuously.
Cancer Chemother Pharmacol
; 52(5): 361-6, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12904896
11.
Chemotherapy for advanced non-small cell lung cancer.
Hematol Oncol Clin North Am
; 18(1): 101-14, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15005284
12.
Update in lung cancer 2007.
Am J Respir Crit Care Med
; 177(9): 941-6, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18434333
13.
Targeted MET inhibition in castration-resistant prostate cancer: a randomized phase II study and biomarker analysis with rilotumumab plus mitoxantrone and prednisone.
Clin Cancer Res
; 19(1): 215-24, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23136195
14.
A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307.
J Thorac Oncol
; 5(10): 1655-61, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20736856
15.
ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: expert panel on radiation oncology-lung.
Int J Radiat Oncol Biol Phys
; 78(4): 969-74, 2010 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20813465
16.
ACR Appropriateness Criteria: nonsurgical treatment for non-small-cell lung cancer: good performance status/definitive intent.
Curr Probl Cancer
; 34(3): 228-49, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20541060
17.
Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study.
J Thorac Oncol
; 4(4): 522-6, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19347984
18.
A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies.
Clin Cancer Res
; 15(17): 5569-75, 2009 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19706807
19.
Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.
Oncologist
; 12(3): 331-7, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17405898
20.
Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond.
Lancet Oncol
; 7(5): 416-24, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16648046